multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
involv
complex
interact
immun
system
neural
cell
anim
model
critic
address
ms
pathogenesi
three
character
anim
model
ms
experiment
autoimmuneallerg
encephalomyel
eae
virallyinduc
chronic
demyelin
diseas
known
theiler
murin
encephalomyel
viru
tmev
infect
toxininduc
demyelin
model
complementari
way
allow
reach
good
knowledg
pathogenesi
ms
specif
eae
model
better
reflect
autoimmun
pathogenesi
ms
extrem
use
studi
potenti
experiment
treatment
furthermor
tmev
toxininduc
demyelin
model
suitabl
character
role
axon
injuryrepair
remyelin
process
ms
conclus
anim
model
despit
limit
remain
use
instrument
implement
studi
ms
multipl
sclerosi
ms
chronic
immunemedi
demyelin
diseas
central
nervou
system
cn
hafler
et
al
repres
lead
caus
nontraumat
disabl
among
young
adult
great
socioeconom
impact
develop
countri
ms
heterogen
diseas
inde
clinic
sign
symptom
variabl
depend
part
affect
cn
brain
spinal
cord
includ
motor
sensori
autonom
cognit
disabl
noseworthi
et
al
run
least
three
clinic
cours
relapsingremit
rr
frequent
character
exacerb
subsequ
period
clinic
stabil
secondari
progress
sp
primaryprogress
pp
subtyp
noseworthi
et
al
cn
tissu
multipl
sclerosi
patient
show
discret
lesion
inflammatori
infiltr
demyelin
astrogliosi
earli
axon
damag
ms
wide
consid
autoimmun
demyelin
diseas
autoimmun
reaction
myelinspecif
helper
cell
initi
neuropatholog
describ
hafler
et
al
sospedra
martin
specif
caus
pathogenesi
ms
identifi
far
although
sever
genet
environment
risk
factor
suggest
play
central
role
context
anim
model
ms
allow
explor
mechan
diseas
initi
progress
test
sever
novel
therapeut
approach
diseas
question
whether
anim
model
could
realli
repres
good
model
ms
sinc
perfectli
reflect
aspect
human
diseas
particular
diseas
initi
usual
highli
artifici
anim
model
induc
activ
immun
autoantigen
also
timefram
clinic
symptom
onset
differ
human
mice
human
physiolog
process
underli
diseas
undetect
year
onset
clinic
manifest
symptom
anim
model
detect
within
week
even
day
induct
diseas
moreov
treatment
therapi
studi
start
earli
cours
induc
autoimmun
diseas
wherea
therapi
human
administ
late
phase
diseas
importantli
experiment
studi
use
inbr
strain
mice
genet
homogen
often
mice
may
accumul
genet
irregular
difficult
find
human
popul
although
becom
clear
rodent
human
immun
system
profound
differ
evolutionarili
distant
share
essenti
principl
context
avail
three
major
anim
model
ms
allow
understand
relev
featur
human
ms
commonli
studi
anim
model
ms
experiment
autoimmuneallerg
encephalomyel
eae
viral
induc
model
mainli
theiler
murin
encephalomyel
viru
tmev
infect
consequenti
chronic
demyelin
toxininduc
model
demyelin
cuprizon
lysophosphatidylcholin
lysolecithin
model
ms
chronic
immunemedi
inflammatori
disord
cn
frohman
et
al
moststudi
anim
model
ms
experiment
autoimmun
encephalomyel
eae
autoimmun
cn
compon
induc
suscept
mice
immun
selfantigen
deriv
basic
myelin
protein
river
et
al
firstli
describ
monkey
immun
rabbit
brain
extract
paralyisi
associ
perivascular
infiltr
demyelin
brain
spinal
cord
acut
dissemin
encephalomyel
later
call
experiment
autoimmun
encephalomyel
eae
freund
adjuv
cfa
freund
mcdermott
pertussi
toxin
pt
munoz
et
al
later
ad
potenti
humor
immun
respons
induc
oscillatori
symptom
typic
relapsingremit
diseas
kabat
et
al
similar
found
ms
patient
experi
also
perform
anim
speci
guinea
pig
freund
et
al
monkey
kabat
et
al
morgan
howev
mice
olitzki
yager
rat
lipton
freund
result
best
model
evalu
acut
monophas
relapsingremit
chronic
progress
eae
immunogenet
histopatholog
therapeut
studi
eae
mice
character
ascend
paralysi
begin
tail
batouli
et
al
follow
limb
forelimb
paralysi
assess
use
scale
mcrae
et
al
rangachari
et
al
berard
et
al
eae
may
induc
mice
differ
genet
background
sjlj
nod
either
activ
immun
protein
peptid
passiv
transfer
encephalitogen
cell
case
relev
immunogen
deriv
selfcn
protein
myelin
basic
protein
mbp
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
immun
sjlj
mice
immunodomin
epitop
plp
plp
induc
relapsingremit
rr
diseas
cours
tuohi
et
al
diseas
induc
immunodomin
mog
peptid
mice
chronic
natur
tompkin
et
al
recent
varieti
addit
antigen
suppos
involv
autoimmun
reaction
ms
eae
myelin
constitu
neurofascin
nf
mathey
et
al
other
express
myelin
axon
axon
derfuss
et
al
entir
nonmyelin
antigen
neuron
membran
protein
neurofascin
nf
mathey
et
al
neuron
cytoskelet
protein
zamvil
et
al
mcrae
et
al
whitham
et
al
miyagawa
et
al
adlard
et
al
chronic
eae
mendel
et
al
berard
et
al
hjelmstrom
et
al
bullard
et
al
koh
et
al
baron
et
al
eae
therapeut
trial
design
repress
demyelin
acceler
remyelin
jefferi
blakemor
shield
et
al
bieber
et
al
neurofilamentm
krishnamoorthi
et
al
astrocytetyp
protein
relapsingremit
eae
rreae
sjlj
mous
model
zamvil
et
al
abl
induc
eae
sjlj
mice
use
mbpderiv
peptid
mbpreactiv
cell
clone
tabl
initi
studi
suggest
mbp
abl
induc
eae
howev
studi
demonstr
sjlj
mice
could
immun
induct
eae
synthet
myelin
plp
identifi
immunodomin
epitop
myelin
without
omolog
mbp
mcrae
et
al
whitham
et
al
inde
major
plp
immun
mice
show
sever
relaps
remiss
initi
attack
moreov
rreae
could
also
induc
passiv
transfer
plpreactiv
cell
line
classic
model
adopt
transfer
involv
immun
donor
mice
plpderiv
peptid
isol
peripher
lymphoid
cell
day
cultur
vitro
restimul
subsequ
transfer
recipi
despit
model
use
demonstr
central
role
pathogenesi
eae
sever
limit
use
research
field
inde
difficult
isol
peripher
lymph
node
cell
direct
specif
antigen
epitop
encephalitogen
capac
transfer
cell
necessarili
reflect
vivo
condit
donor
anim
decreas
capabl
knockout
cell
transfer
diseas
could
exampl
reflect
defect
antigen
present
donor
anim
rather
alter
cell
function
lesion
aspect
combin
pleiotrop
natur
immun
gene
express
make
difficult
use
adopt
transfer
model
defin
contribut
individu
gene
encephalitogen
cell
function
develop
cell
receptor
tcr
transgen
mous
model
past
year
greatli
help
studi
antigenspecif
cell
respons
cell
result
transgen
anim
escap
recombin
tcr
loci
express
transgen
tcr
high
frequenc
cell
tcr
transgen
mice
specif
defin
epitop
may
either
ectop
selfderiv
miyagawa
et
al
mbp
specif
tcr
transgen
mice
first
gener
shown
develop
spontan
paralyt
diseas
plj
background
adlard
et
al
consequ
also
tcr
transgen
mous
line
sjlj
background
specif
plp
gener
studi
pathogen
mechan
eae
sever
peptid
could
induc
cell
respons
upon
ex
vivo
restimul
mog
abl
induc
directli
cn
autoimmun
concomit
administr
pertussi
toxin
pt
abl
enhanc
diseas
onset
sever
tabl
differ
plp
mog
abl
induc
chronic
form
diseas
remit
mendel
et
al
howev
berard
et
al
report
rel
high
dose
peptid
adjuv
induc
chronic
nonremit
eae
mice
lower
dose
peptideadjuv
could
promot
relapsingremit
diseas
cours
thu
suggest
peptid
dosag
essenti
type
diseas
develop
upon
mog
immun
mog
eae
also
allow
obtain
grow
number
evid
role
immun
system
pathogenesi
ms
elucid
contribut
b
cell
hjelmstrom
et
al
monocyt
bullard
et
al
tcell
koh
et
al
cell
baron
et
al
pathogenesi
eae
ms
bettelli
et
al
firstli
gener
class
iirestrict
tcr
transgen
model
studi
mog
inducedea
use
background
tabl
epitopereact
cell
clone
obtain
express
chain
react
specif
mog
mice
also
show
sever
eae
nontransgen
litterm
high
frequenc
develop
spontan
eae
anoth
transgen
mous
model
use
studi
eae
b
cell
heavi
chain
knockin
mous
strain
igh
mog
also
known
th
contain
high
frequenc
antimog
antibodysecret
b
cell
peripher
repertoir
upon
activ
immun
recombin
mog
igh
mog
anim
develop
eae
typic
inflammatori
lesion
higher
frequenc
nontransgen
litterm
litzenburg
et
al
tabl
howev
mice
develop
spontan
eae
emphas
necess
myelin
specif
cell
order
progress
diseas
howev
last
eae
model
show
disadvantag
clonal
heterogen
cell
popul
gener
immun
sever
helper
cell
lineag
vivo
without
possibl
delin
specif
cell
subset
involv
recent
et
al
develop
model
allow
gener
differ
helper
subset
induc
eae
model
cell
stimul
vitro
transfer
absenc
antigenpres
cell
apc
specif
isol
cell
stimul
vitro
use
antibodi
cultur
variou
combin
cytokin
block
antibodi
gener
subset
subsequ
transfer
host
anim
last
experi
allow
delin
central
role
subset
pathogenesi
diseas
recent
evid
indic
nonobes
diabet
nod
strain
mice
spontan
develop
diabet
also
suscept
eae
upon
activ
immun
mog
specif
anim
display
rr
diseas
cours
follow
chronic
nonremit
stage
encina
et
al
much
similar
diseas
cours
observ
ms
moreov
anderson
colleagu
creat
tcr
transgen
model
mog
driven
eae
nod
background
display
mog
reactiv
cell
cell
alon
induc
optic
neuriti
mild
eae
delay
onset
howev
cell
alon
abl
induc
sever
eae
predomin
lesion
cell
type
present
thu
support
central
role
cell
pathogenesi
diseas
anderson
et
al
substanti
evid
ms
subject
indic
cell
play
key
role
pathogenesi
diseas
fries
fugger
goverman
mar
et
al
cell
found
repres
cell
acut
chronic
cn
lesion
ms
patient
woodroof
et
al
hauser
et
al
monteiro
et
al
jacobsen
et
al
junker
et
al
importantli
immunotherapi
specif
target
cell
fail
show
signific
clinic
benefit
ms
cours
wherea
therapi
affect
leukocyt
improv
diseas
progress
cole
et
al
latter
observ
led
develop
anim
model
ms
use
mogimmun
mice
studi
role
cell
pathogenesi
diseas
specif
ford
evavold
identifi
mog
minim
peptid
abl
induc
specif
cell
respons
mice
mogimmun
mice
background
also
contribut
identif
cell
nowaday
consid
major
effector
cell
eae
provid
explan
strong
correl
ms
suscept
particular
mhc
class
ii
allel
cell
initi
consid
effector
cell
subset
induc
eae
sospedra
martin
inde
adopt
transfer
clone
mice
defici
tbet
transcript
factor
requir
cell
differenti
resist
eae
induct
baron
et
al
segal
shevach
bettelli
et
al
recent
find
interleukin
requir
eae
develop
becher
et
al
led
identif
subset
well
establish
role
cell
pathogenesi
ms
eae
inde
cell
identifi
cn
csf
ms
subject
traugott
lebon
link
et
al
kebir
et
al
lock
et
al
abromsonleeman
et
al
peter
et
al
recent
studi
identifi
differ
type
inflammatori
infiltr
cn
cell
shown
correl
predominantli
monocyt
cn
infiltr
cell
associ
higher
proport
neutrophil
cn
infiltr
kroenk
et
al
addit
clinic
symptom
eae
found
differ
cell
induc
classic
eae
wherea
cell
induc
eae
sever
clinic
phenotyp
cua
et
al
langrish
et
al
et
al
often
character
atyp
manifest
stromn
et
al
domingu
et
al
also
recent
evid
show
cell
coexpress
kurschu
et
al
cell
identifi
ms
brain
kebir
et
al
understand
role
cytokin
anim
model
genet
defici
develop
suscept
eae
character
studi
show
requir
eae
induct
suggest
may
rather
suppress
activ
ferber
et
al
wenski
et
al
contrast
ms
subject
shown
supplement
exacerb
diseas
manifest
thu
suggest
diseaseenhanc
diseasesuppress
activ
panitch
et
al
regard
studi
cell
receptor
adefici
mous
model
show
reduc
incid
sever
delay
onset
eae
hofstett
et
al
komiyama
et
al
hu
et
al
addit
clinic
trial
rrm
subject
treat
neutral
monoclon
antibodi
report
reduct
lesion
activ
trend
toward
reduc
relaps
rate
elain
et
al
support
central
role
cell
cytokin
pathogenesi
ms
discoveri
cell
treg
express
master
gene
forkhead
box
key
player
control
immun
toler
allow
establish
impair
number
function
cell
autoimmun
disord
ms
kleinewietfeld
hafler
major
studi
conduct
eae
mice
adopt
transfer
cell
subset
reduc
diseas
sever
kohm
et
al
contrari
administr
antibodi
reduc
tregmedi
protect
zhang
et
al
furthermor
use
report
mice
facilit
detail
studi
treg
activ
use
mice
show
popul
treg
cell
cn
initi
small
rapidli
expand
eae
major
treg
cn
eae
mice
found
antigen
specif
addit
support
approach
came
studi
demonstr
impair
function
treg
patient
ms
compar
healthi
control
treg
isol
peripher
blood
csf
ms
subject
significantli
reduc
suppress
function
frisullo
et
al
viglietta
et
al
haa
et
al
treg
ms
subject
also
exhibit
greater
tendenc
express
compar
healthi
control
dominguezvillar
et
al
recent
contribut
treg
function
identifi
risk
allel
suscept
ms
suggest
intrins
treg
defect
baranzini
zenewicz
et
al
broux
et
al
de
jager
et
al
treat
ms
patient
appear
restor
suppress
function
treg
de
et
al
korpor
et
al
thu
discoveri
enhanc
treg
activ
amelior
eae
well
studi
treg
activ
use
report
mice
provid
insight
current
therapi
led
new
therapeut
strategi
target
pathway
enhanc
treg
function
howev
note
caution
also
emerg
studi
use
eae
model
treg
isol
cn
peak
diseas
abl
suppress
peripher
effector
cell
fail
inhibit
myelinspecif
effector
cell
isol
cn
observ
suggest
effector
cell
inflam
cn
may
resist
suppress
treg
korn
et
al
last
year
seri
molecul
known
play
function
metabol
also
shown
play
import
role
regul
immun
respons
context
adipocytederiv
hormon
leptin
shown
regul
immun
respons
normal
well
patholog
condit
sever
studi
eae
mice
conduct
studi
role
leptin
ms
shown
leptindefici
obob
mice
resist
seri
experiment
induc
autoimmun
disord
includ
eae
normal
wildtyp
mice
show
increas
secret
leptin
serum
upon
eae
induct
brain
inflammatori
infiltr
stain
posit
leptin
sanna
et
al
author
also
show
invers
relationship
leptin
secret
frequenc
treg
cell
patient
ms
matares
et
al
leptin
neutral
leptin
antagonist
improv
eae
cours
profoundli
alter
intracellular
signal
myelinreact
cell
increas
number
treg
cell
de
rosa
et
al
data
suggest
leptin
consid
link
among
immun
toler
metabol
state
autoimmun
strategi
aim
interf
leptin
axi
could
repres
innov
therapeut
tool
autoimmun
disord
recent
observ
reveal
increas
intrathec
product
immunoglobulin
ig
csf
patient
ms
owen
et
al
thu
suggest
b
cell
involv
ms
eae
pathogenesi
b
cell
defici
mice
deplet
use
investig
role
b
cell
eae
wildtyp
mice
exhibit
similar
suscept
mbppeptid
induc
eae
wolf
et
al
howev
eae
induc
immun
recombin
human
mog
protein
wildtyp
mice
oliv
et
al
lyon
et
al
thu
suggest
key
role
display
antibodi
immun
human
mog
protein
gener
cnsinflamm
similar
result
obtain
mice
express
transgen
tcr
specif
mog
develop
low
incid
spontan
eae
bettelli
et
al
model
spontan
rreae
sjlj
mice
express
transgen
mogspecif
tcr
b
cell
deplet
suppress
eae
mice
provid
support
pathogen
role
b
cell
efficaci
rituximab
antibodi
reduc
inflammatori
lesion
clinic
relaps
patient
rrm
provid
anoth
support
pathogen
role
b
cell
ms
hauser
et
al
eae
model
significantli
contribut
knowledg
autoimmun
neuroinflamm
chang
cours
ms
understand
thu
allow
develop
novel
therapeut
approach
diseas
nonetheless
also
sever
limit
use
anim
model
differ
pathogenesi
eae
compar
ms
specif
use
mice
allow
studi
relaps
rate
remyelin
difficult
studi
eae
lesion
occur
stochast
regard
time
local
furthermor
mechanist
insight
myelin
damag
eae
tissu
perform
far
studi
aim
evalu
potenti
benefit
novel
therapeut
treatment
neuron
growth
surviv
factor
unsatisfactori
effect
offtarget
make
result
difficult
interpret
oliv
et
al
eae
mainli
diseas
affect
spinal
cord
white
matter
wherea
ms
mainli
brain
diseas
promin
demyelin
cerebr
cerebellar
cortex
unfortun
studi
analyz
involv
cortex
eae
form
eae
gener
immun
selfpeptid
determin
cell
activ
studi
address
role
cell
contrari
mainli
act
ms
lesion
show
clonal
expans
activ
lyon
et
al
eae
studi
extens
analyz
role
b
cell
pathogenesi
diseas
bettelli
et
al
despit
recent
clinicaltri
studi
clearli
shown
import
hauser
et
al
epidemiolog
studi
suggest
viral
infect
earli
life
presenc
specif
genet
background
may
induc
immunemedi
attack
cn
poser
dal
canto
lipton
mcfarlin
mcfarland
kurtzk
howev
specif
viru
identifi
potenti
caus
contributor
ms
date
recent
epsteinbarr
viru
ebv
infect
link
ms
critic
environment
suscept
factor
de
jager
et
al
ascherio
munger
ascherio
et
al
viral
infect
cn
induc
demyelin
mice
best
studi
picornaviru
theiler
murin
encephalomyel
viru
tmev
certain
strain
coronaviru
mous
hepat
viru
mhv
tmev
nonenvelop
posit
sens
singl
strand
rna
viru
tsunoda
fujinami
tabl
repres
one
neurotrop
viral
infect
model
ms
tmev
divid
two
subgroup
gdvii
base
abil
caus
diseas
cn
gdvii
subgroup
strain
gdvii
fa
highli
neurovirul
mice
induc
death
within
week
da
bean
strain
subgroup
induc
acut
polioencephalomyel
unlik
eae
diseas
alway
chronicprogress
suscept
mice
tmev
induc
inflammatori
demyelin
diseas
mice
owen
differ
speci
rodent
primat
gdvii
viru
predominantli
infect
neuron
tsunoda
et
al
die
neuron
display
chromatin
condens
apoptot
fragment
nuclei
karyorrhexi
absenc
inflammatori
mononuclear
cell
mnc
recruit
contrast
gdvii
infect
parenchym
well
perivascular
subarachnoid
mnc
infiltr
includ
cell
present
gray
matter
brain
tsunoda
et
al
acut
phase
da
infect
chronic
phase
da
infect
month
infect
inflamm
gray
matter
cn
subsid
ure
rodriguez
although
axon
damag
observ
ms
anim
model
eae
believ
axon
damag
occur
secondarili
sever
inflammatori
demyelin
lesion
develop
outsid
myelin
insid
axon
outsidein
model
tsunoda
et
al
contrari
tmev
infect
axon
damag
preced
demyelin
tsunoda
et
al
insideout
model
distribut
damag
axon
observ
earli
phase
correspond
region
subsequ
inflammatori
demyelin
occur
chronic
phase
tabl
evid
suggest
axon
degener
trigger
recruit
cell
macrophag
cn
lead
subsequ
loss
myelin
tmev
persist
infect
macrophagemicroglia
lineag
cell
oligodendrocyt
astrocyt
chronic
phase
lipton
et
al
macrophag
suggest
play
effector
role
demyelin
sinc
deplet
amelior
tmevinduc
demyelin
intracerebr
inocul
tmevinfect
macrophag
cell
line
induc
acut
focal
demyelin
rossi
et
al
rodriguez
quddu
confirm
role
humor
immun
pathogenesi
tmevinduc
neurodeger
serum
antitmev
neutral
antibodi
respons
detect
within
week
infect
high
neutral
antibodi
titer
seen
mice
persist
tmev
infect
tsunoda
et
al
moreov
adopt
transfer
neutral
antibodi
tmevinfect
nude
mice
result
viral
clearanc
fujinami
et
al
suggest
virusspecif
antibodi
play
role
viral
protect
clearanc
vivo
context
also
tmevspecif
cell
play
import
role
demyelin
testifi
infiltr
demyelin
lesion
evid
vivo
deplet
cell
diminish
sever
demyelin
howev
gereti
et
al
shown
tmev
specif
cell
alon
induc
demyelin
home
viru
specif
cell
cn
requir
previou
viru
infect
cn
moreov
recent
shown
treatment
tmev
infect
mice
ex
vivo
gener
induc
treg
itreg
worsen
clinic
sign
ms
treatment
perform
earli
phase
diseas
protect
treatment
perform
chronic
phase
increas
product
b
cell
cell
dendrit
cell
may
contribut
decreas
cn
inflamm
martinez
et
al
regard
cell
shown
cell
infiltr
demyelin
lesion
vivo
administr
antibodi
diminish
demyelin
sjl
mice
show
minim
deficit
effect
extent
demyelin
murray
et
al
mhc
class
molecul
upregul
cn
tmevinfect
mice
thu
suggest
cell
play
effector
role
tmevinduc
demyelin
howev
recent
report
also
demonstr
tmev
infect
result
induct
autoreact
ctl
recogn
viru
host
antigen
potenti
lead
cn
patholog
tsunoda
et
al
tmev
infect
intercellular
adhes
molecul
icam
leukocyt
function
associ
antigen
lfa
vascular
cell
adhes
molecul
vcam
upregul
cn
olson
et
al
inhibit
result
suppress
demyelin
diseas
sjl
mice
mestr
et
al
addit
decreas
number
cell
brain
adhesionmolecul
delet
mice
compar
control
mice
detect
njenga
et
al
tmev
model
eae
display
sever
import
differ
requir
viral
persist
immun
system
activ
neuropathogenet
mechan
clinic
cours
main
posit
aspect
tmev
model
follow
virusinduc
patholog
clear
similar
ms
clinic
manifest
similar
observ
human
chronic
progress
ms
patholog
featur
virusinduc
demyelin
diseas
gener
mediat
activ
immun
system
direct
toxic
effect
mediat
viru
target
cell
tmev
model
use
test
new
therapeut
approach
particularli
therapi
target
adhes
molecul
axon
degener
immunosuppress
main
neg
aspect
limit
use
follow
unlik
eae
induc
sever
differ
speci
rodent
primat
tmev
induc
inflammatori
demyelin
diseas
mice
specif
caus
patholog
human
aspect
rais
question
whether
ration
use
nonhuman
pathogen
character
human
diseas
ms
pathogenesi
tmevinduc
demyelin
part
differ
human
ms
persist
viral
infect
cn
demonstr
addit
wellcharacter
experiment
approach
induc
demyelin
mice
autoimmun
inflammatoryinduc
demyelin
eae
also
viralinduc
demyelin
toxic
demyelin
perform
pachner
tabl
eae
commonli
use
model
reflect
autoimmun
origin
ms
toxic
demyelin
suitabl
studi
deand
remyelin
process
blakemor
franklin
two
common
agent
util
induc
demyelin
cuprizon
lysolecithin
cuprizon
biscyclohexanoneoxaldihydrazon
copper
chelat
reagent
supplement
normal
rodent
chow
caus
oligodendrogli
cell
death
subsequ
demyelin
togeth
profound
activ
astrocyt
microglia
matsushima
morel
tabl
specif
target
cuprizon
matur
oligodendrocyt
fail
fulfil
extens
metabol
demand
consequ
undergo
apoptosi
cell
type
affect
main
reason
metabol
failur
copper
defici
due
copper
chelat
properti
cuprizon
reason
oligodendrocyt
cellular
subset
suscept
effect
still
remain
unclear
liu
et
al
lucchinetti
et
al
demyelin
complet
new
oligodendrocyt
gener
pool
oligodendrocyt
progenitor
opc
begin
form
new
myelin
sheath
soon
remov
cuprizon
diet
matsushima
morel
despit
experiment
use
cuprizon
specif
mechan
action
reason
underli
oligodendrocyt
damag
complet
known
inde
copper
administr
togeth
cuprizon
administr
reduc
toxic
effect
reason
copperchel
properti
cuprizon
seem
mechanicist
explan
mani
evid
suggest
oligodendrogli
apoptosi
mainli
reli
mitochondri
disturb
sinc
enlarg
giant
mitochondria
observ
liver
brain
cuprizonetr
mice
suzuki
hemm
et
al
komoli
et
recent
strong
reduct
mitochondri
potenti
also
report
cuprizonetr
oligodendrocyt
vitro
benardai
et
al
taken
togeth
evid
suggest
regular
mithocondri
function
essenti
oligodendrogli
bioenerget
demand
requir
larg
amount
oxygen
adenosin
triphosphat
atp
support
extens
membran
synthesi
although
appropri
studi
autoimmun
mediat
demyelin
cuprizon
model
suitabl
tool
studi
basic
mechan
deand
remyelin
absenc
primarili
immunemedi
phenomena
matsushima
morel
cuprizon
fed
continu
remyelin
abort
demyelin
persist
end
diet
chronic
demyelin
case
remyelin
capac
retain
withdraw
cuprizon
diet
strongli
decreas
matsushima
morel
lysolecithin
activ
phospholipas
induc
focal
area
demyelin
upon
inject
spinal
cord
sever
anim
includ
cat
rabbit
rat
mous
jefferi
blakemor
tabl
demyelin
occur
due
primari
toxic
effect
deterg
myelin
sheath
rather
secondari
effect
oligodendrocyt
hall
lysolecithin
trigger
rapid
highli
reproduc
form
demyelin
cn
without
produc
much
damag
adjac
cell
axon
immunemedi
sinc
occur
even
immunedefici
mice
howev
chronic
inflamm
lesion
minim
young
anim
use
complet
remyelin
occur
week
contrari
repair
older
anim
much
slower
shield
et
al
acut
phase
immedi
follow
lysolecithin
inject
lesion
site
infiltr
cell
b
cell
macrophag
neutrophil
seem
involv
cn
repair
bieber
et
al
infiltr
activ
macrophag
microglia
begin
within
hour
inject
last
mani
day
role
cell
type
play
establish
environ
remyelin
occur
complet
known
well
accept
tcell
respons
promot
express
differ
neurotrophin
macrophag
astrocyt
sustain
neuron
protect
surviv
remyelin
process
sever
growth
factor
produc
cell
might
play
similar
role
support
oligodendrocyt
remyelin
directli
indirectli
stimul
activ
cn
glia
moreov
deplet
macrophag
impair
per
se
oligodendrocyt
remyelin
thu
suggest
key
role
popul
myelin
repair
process
taken
togeth
evid
suggest
toxin
induc
demyelin
model
compar
eae
viru
induc
demyelin
syndrom
reflect
ms
diseas
mainli
establish
system
studi
process
deand
remyelin
blakemor
franklin
develop
success
failur
novel
therapi
ms
test
anim
model
eae
model
histor
use
preclin
assess
defin
util
novel
ms
therapi
spectrum
agent
show
promis
result
eae
extens
rang
natur
compound
modern
genet
manipul
immun
system
cytokin
antigen
import
exampl
context
repres
glatiram
acet
mitoxantron
natalizumab
kieseier
hartung
steinman
zamvil
glatiram
acet
prepar
random
polym
consist
repeat
sequenc
four
amino
acid
shown
suppress
eae
progress
probabl
stimul
antimbp
immun
respons
aharoni
et
al
aharoni
et
al
induc
kill
antigenpres
cell
apc
gener
treg
cell
rack
et
al
mitoxantron
first
proven
power
immunosuppress
drug
eae
ridg
et
al
secondlin
compon
ms
therapi
hartung
et
al
cytotox
effect
lymphocyt
induct
apoptosi
apc
propos
major
mechan
action
drug
neuhau
et
al
vollmer
et
al
also
natalizumab
monoclon
antibodi
mab
inhibit
transmigr
immun
cell
inflam
parenchyma
lymphat
organ
cn
shown
effect
prevent
eae
rice
et
al
yednock
et
al
first
mab
approv
therapeut
trial
ms
polman
et
al
inde
repres
secondlin
drug
ms
therapeut
approach
recent
critic
eae
rais
fact
sever
therapeut
approach
show
promis
result
mous
model
shown
either
ineffici
case
harm
human
ms
steinman
zamvil
exampl
blockad
three
differ
cytokin
whose
activ
report
import
inflamm
eae
tnfa
baff
found
either
worsen
ms
meinl
et
al
effect
human
longbrak
rack
hold
true
neuroprotect
polypeptid
hormon
ciliari
neurotroph
factor
cntf
elicit
acutephas
respons
rat
liver
dittrich
et
al
antiadhes
molecul
mab
morrissey
et
al
inhibitor
rolipram
despit
effect
role
suppress
eae
fail
suppress
inflammatori
activ
pilot
trial
patient
relapsingremit
ms
bielekova
et
al
moreov
clinic
studi
aim
induc
oral
toler
antigenspecif
toler
potenti
encephalitogen
autoantigen
mbp
either
worsen
diseas
chang
clinic
cours
bielekova
et
al
kappo
et
al
report
likewis
benefici
effect
antibodi
therapi
progress
ms
despit
profound
decreas
cell
peripher
blood
van
oosten
et
al
lindsey
et
al
reason
discrep
result
obtain
anim
human
system
could
due
differ
genet
natur
differ
pathogenet
mechan
kinet
tempor
differ
immun
reactiv
respons
therapi
addit
ms
bloodbrain
barrier
bbb
may
insuffici
disrupt
compar
eae
therebi
prevent
therapeut
molecul
reach
target
within
cn
reason
eae
consid
sometim
mislead
model
ms
sriram
steiner
scientist
truli
think
eae
suitabl
studi
immunogenet
histopatholog
rather
screen
new
treatment
mix
et
al
anim
model
eae
continu
play
key
role
firstlin
model
system
develop
novel
therapeut
approach
ms
especi
shed
light
specif
mechanist
question
nonetheless
great
number
anim
model
develop
ms
garner
consist
critic
often
result
disappoint
failur
import
rememb
singl
anim
model
reflect
entir
spectrum
heterogen
ms
research
field
lack
focus
diseas
model
progress
ms
approach
complex
ms
current
progress
human
entir
immun
system
rodent
sure
provid
substanti
advantag
explor
novel
immunemodulatori
approach
appropri
model
conclus
despit
clearli
exist
limit
basic
scienc
ms
continu
reli
model
new
drug
develop
better
comprehens
differ
pathogen
mechan
ms
